Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Therapeutic Equivalency
Interventions
DRUG

Primidone 50 mg Tablet

50 mg tablet administered after an overnight fast of at least 10 hours.

DRUG

Primidone (Mysoline®) 50 mg Tablet

50 mg tablet administered after an overnight fast of at least 10 hours.

All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00685165 - Fasted Bioequivalence Study of Primidone Tablets and Mysoline Tablets | Biotech Hunter | Biotech Hunter